BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23254508)

  • 1. Cytotoxic effects of adenovirus- and lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleoside kinase on Bcap37 breast cancer cells.
    Zhang N; Dong X; Sun Y; Cai X; Zheng C; He A; Xu K; Zheng X
    Oncol Rep; 2013 Mar; 29(3):960-6. PubMed ID: 23254508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent anticancer effects of lentivirus encoding a Drosophila melanogaster deoxyribonucleoside kinase mutant combined with brivudine.
    Zhang NQ; Zhao L; Ma S; Gu M; Zheng XY
    Asian Pac J Cancer Prev; 2012; 13(5):2121-7. PubMed ID: 22901180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
    Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X
    Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditionally replicating adenovirus SG500-expressed mutant Dm-dNK gene for breast cancer therapy.
    Qu W; Zhu Z; Zhao L; He A; Zheng X
    Int J Oncol; 2012 Dec; 41(6):2175-83. PubMed ID: 23064407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrovirus-mediated Drosophila melanogaster multisubstrate deoxyribonucleoside kinase gene therapy of gastric cancer cells in vitro and in vivo.
    Zhu Z; Zhao L; He A; Huang B; Karlsson A; Xu H; Zheng X
    Anticancer Res; 2010 Jul; 30(7):2641-9. PubMed ID: 20682993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lentivirus-mediated expression of Drosophila melanogaster deoxyribonucleoside kinase driven by the hTERT promoter combined with gemcitabine: a potential strategy for cancer therapy.
    Zhang N; Zhao L; Ma S; Gu M; Zheng X
    Int J Mol Med; 2012 Sep; 30(3):659-65. PubMed ID: 22710559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent antitumoral effects of targeted promoter-driven oncolytic adenovirus armed with Dm-dNK for breast cancer in vitro and in vivo.
    Dong X; Qu W; Ma S; Zhu Z; Zheng C; He A; Karlsson A; Xu K; Zheng X
    Cancer Lett; 2013 Jan; 328(1):95-103. PubMed ID: 23000515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic antitumor effect of adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase and nucleoside analogs for human breast carcinoma in vitro and in vivo.
    Tang M; Zu C; He A; Wang W; Chen B; Zheng X
    Drug Des Devel Ther; 2015; 9():3301-12. PubMed ID: 26203222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Combination Oncolytic Adenoviral Gene Therapy Armed with Dm-dNK and CD40L for Breast Cancer.
    Wang Q; Yang M; Zhang Y; Zhong L; Zheng X
    Curr Gene Ther; 2019; 19(1):54-65. PubMed ID: 30848201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster as a therapeutic suicide gene of breast cancer cells.
    Ma S; Zhao L; Zhu Z; Liu Q; Xu H; Johansson M; Karlsson A; Zheng X
    J Gene Med; 2011 Jun; 13(6):305-11. PubMed ID: 21674733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial expression of the Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.
    Solaroli N; Zheng X; Johansson M; Balzarini J; Karlsson A
    Mol Pharmacol; 2007 Dec; 72(6):1593-8. PubMed ID: 17855655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic therapeutic effect in gastric cancer cells produced by oncolytic adenovirus encoding Drosophila melanogaster deoxyribonucleoside kinase.
    Zhu Z; Mao L; Zhao L; Sun Z; Wang Z; Xu H; Zheng X
    Cancer Biol Ther; 2011 May; 11(10):874-82. PubMed ID: 21383545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated Drosophila melanogaster deoxyribonucleoside kinase mutants combined with gemcitabine harbor a safe cancer treatment profile.
    Zhu Z; Ma S; Zhao L; Sun Z; He A; Xu H; Zheng X
    Int J Oncol; 2011 Mar; 38(3):745-53. PubMed ID: 21186401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bystander effects of cancer cell lines transduced with the multisubstrate deoxyribonucleoside kinase of Drosophila melanogaster and synergistic enhancement by hydroxyurea.
    Zheng X; Johansson M; Karlsson A
    Mol Pharmacol; 2001 Aug; 60(2):262-6. PubMed ID: 11455012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleoside analog cytotoxicity and bystander cell killing of cancer cells expressing Drosophila melanogaster deoxyribonucleoside kinase in the nucleus or cytosol.
    Zheng X; Johansson M; Karlsson A
    Biochem Biophys Res Commun; 2001 Nov; 289(1):229-33. PubMed ID: 11708804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of lentivirus‑mediated Drosophila melanogaster deoxyribonucleoside kinase combined with (E)‑5‑(2‑bromovinyl)‑2'‑deoxyuridine or 1‑β‑D‑arabinofuranosylthymine therapy in human keloid fibroblasts.
    Sun Y; Jiang H; Gu M; Zheng X
    Mol Med Rep; 2018 Aug; 18(2):1660-1665. PubMed ID: 29901093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral transduction of cancer cell lines with the gene encoding Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.
    Zheng X; Johansson M; Karlsson A
    J Biol Chem; 2000 Dec; 275(50):39125-9. PubMed ID: 10993893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated interleukin-12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice.
    Hwang KS; Cho WK; Yoo J; Yun HJ; Kim S; Im DS
    BMC Cancer; 2005 May; 5():51. PubMed ID: 15910693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R; Wang X; Li B; Lin F; Dong K; Gao P; Zhang HZ
    Breast Cancer Res Treat; 2009 Sep; 117(1):45-54. PubMed ID: 18791823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.